Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study

Abstract Thyroid cancer patients have a good prognosis, and their long survival increases the likelihood of developing a second primary tumor. Meanwhile, pancreatic cancer (PC) has a poor prognosis and therapeutic efficacy. However, the association between prior thyroid cancer and the subsequent PC...

Full description

Bibliographic Details
Main Authors: Jun He, Yu Wang, Xiangmei Chen, Wenxiang Chen, Jianyin Zhou
Format: Article
Language:English
Published: Nature Portfolio 2023-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-32635-z
_version_ 1797850113749549056
author Jun He
Yu Wang
Xiangmei Chen
Wenxiang Chen
Jianyin Zhou
author_facet Jun He
Yu Wang
Xiangmei Chen
Wenxiang Chen
Jianyin Zhou
author_sort Jun He
collection DOAJ
description Abstract Thyroid cancer patients have a good prognosis, and their long survival increases the likelihood of developing a second primary tumor. Meanwhile, pancreatic cancer (PC) has a poor prognosis and therapeutic efficacy. However, the association between prior thyroid cancer and the subsequent PC prognosis is unknown. Herein, we selected pathologically diagnosed PC patients older than 17 between 2010 and 2015 from the SEER database. We used propensity score matching (PSM) to reduce confounding factors between groups and matched each PC patient with a history of thyroid cancer with 10 PC patients without a history of thyroid cancer. Finally, we selected 103 PC patients with prior thyroid cancer and 1030 PC patients without prior thyroid cancer. Then, we analyzed the factors influencing the overall survival (OS) and the cancer-specific survival (CSS) of PC patients. The median overall survival of PC patients with and without a history of thyroid cancer was 12 and 9 months, respectively. The history of thyroid cancer in PC patients reduced the PC-specific mortality (p < 0.05). Prior thyroid cancer might be a favorable prognostic factor for PC-specific mortality in PC patients.
first_indexed 2024-04-09T18:56:12Z
format Article
id doaj.art-9dfb5bcfefbf4620be175e17a3ea5ad4
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T18:56:12Z
publishDate 2023-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-9dfb5bcfefbf4620be175e17a3ea5ad42023-04-09T11:12:47ZengNature PortfolioScientific Reports2045-23222023-04-0113111110.1038/s41598-023-32635-zValue of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based studyJun He0Yu Wang1Xiangmei Chen2Wenxiang Chen3Jianyin Zhou4Department of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen UniversityAbstract Thyroid cancer patients have a good prognosis, and their long survival increases the likelihood of developing a second primary tumor. Meanwhile, pancreatic cancer (PC) has a poor prognosis and therapeutic efficacy. However, the association between prior thyroid cancer and the subsequent PC prognosis is unknown. Herein, we selected pathologically diagnosed PC patients older than 17 between 2010 and 2015 from the SEER database. We used propensity score matching (PSM) to reduce confounding factors between groups and matched each PC patient with a history of thyroid cancer with 10 PC patients without a history of thyroid cancer. Finally, we selected 103 PC patients with prior thyroid cancer and 1030 PC patients without prior thyroid cancer. Then, we analyzed the factors influencing the overall survival (OS) and the cancer-specific survival (CSS) of PC patients. The median overall survival of PC patients with and without a history of thyroid cancer was 12 and 9 months, respectively. The history of thyroid cancer in PC patients reduced the PC-specific mortality (p < 0.05). Prior thyroid cancer might be a favorable prognostic factor for PC-specific mortality in PC patients.https://doi.org/10.1038/s41598-023-32635-z
spellingShingle Jun He
Yu Wang
Xiangmei Chen
Wenxiang Chen
Jianyin Zhou
Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study
Scientific Reports
title Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study
title_full Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study
title_fullStr Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study
title_full_unstemmed Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study
title_short Value of thyroid cancer history in the prognosis of pancreatic cancer: a SEER population-based study
title_sort value of thyroid cancer history in the prognosis of pancreatic cancer a seer population based study
url https://doi.org/10.1038/s41598-023-32635-z
work_keys_str_mv AT junhe valueofthyroidcancerhistoryintheprognosisofpancreaticcanceraseerpopulationbasedstudy
AT yuwang valueofthyroidcancerhistoryintheprognosisofpancreaticcanceraseerpopulationbasedstudy
AT xiangmeichen valueofthyroidcancerhistoryintheprognosisofpancreaticcanceraseerpopulationbasedstudy
AT wenxiangchen valueofthyroidcancerhistoryintheprognosisofpancreaticcanceraseerpopulationbasedstudy
AT jianyinzhou valueofthyroidcancerhistoryintheprognosisofpancreaticcanceraseerpopulationbasedstudy